Hyuck Moon Kwon

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Byeong‐Keuk Kim, Myeong‐Ki Hong, Dong‐Ho Shin et al. · Journal of the American College of Cardiology · 2012 · 636 citations · Full text

Thrombosis, Dual Antiplatelet Therapy, Blood Platelet +5

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents

Hyeon‐Cheol Gwon, Joo‐Yong Hahn, Kyung Woo Park et al. · Circulation · 2011 · 601 citations · Full text

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation

Sung‐Jin Hong, Byeong‐Keuk Kim, Dong‐Ho Shin et al. · JAMA · 2015 · 578 citations · Full text